ProShare Advisors
AH

ProShare Advisors’s Accretive Health AH Stock Holding History

ProShare Advisors’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-37,143
Closed -$339K – 2425
2013
Q3 		$339K Buy
37,143
+470
+1% +$4.67K 0.01% 1800
2013
Q2 		$396K Buy
+36,673
New +$386K 0.01% 1501

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CII
CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

ProShare Advisors's AH Position: Q4 2013 in Review

ProShare Advisors sold out of Accretive Health (AH) in Q4 2013, closing a stake of 37,143 shares — an estimated $339K sold.

ProShare Advisors first reported a position in AH in Q2 2013 and held it in 2 quarters. The position peaked at $396K in Q2 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

  • ProShare Advisors reported no remaining Accretive Health position as of Q4 2013 after selling out during the quarter.
  • ProShare Advisors sold 37,143 Accretive Health shares in Q4 2013, an estimated $339K.
  • ProShare Advisors first reported a position in Accretive Health in Q2 2013 and held it in 2 quarters.
  • ProShare Advisors's Accretive Health position peaked at $396K in Q2 2013.
  • 85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.